86 related articles for article (PubMed ID: 18623465)
21. Fractal kinetic behavior of plasmin on the surface of fibrin meshwork.
Varjú I; Tenekedjiev K; Keresztes Z; Pap AE; Szabó L; Thelwell C; Longstaff C; Machovich R; Kolev K
Biochemistry; 2014 Oct; 53(40):6348-56. PubMed ID: 25222106
[TBL] [Abstract][Full Text] [Related]
22. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
[TBL] [Abstract][Full Text] [Related]
23. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
[TBL] [Abstract][Full Text] [Related]
24. [Index of fibrinolysis with new fibrin plate (author's transl)].
Hishikawa Y; Sugie I
Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
[TBL] [Abstract][Full Text] [Related]
25. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
Hellebrekers BW; Trimbos-Kemper GC; Bakkum EA; Trimbos JB; Declerck PJ; Kooistra T; Emeis JJ
Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
[TBL] [Abstract][Full Text] [Related]
26. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
[TBL] [Abstract][Full Text] [Related]
27. Plasma fibronectin enhances fibrinolytic system in vitro.
Gilboa N; Kaplan JE
Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen assay by means of the lysis time method.
Berg W; Korsan-Bengtsen K; Ygge J
Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
30. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N; Moroi M; Tachiya K
Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
[TBL] [Abstract][Full Text] [Related]
31. Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins.
Gombás J; Tanka-Salamon A; Skopál J; Nagy Z; Machovich R; Kolev K
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):82-8. PubMed ID: 18180621
[TBL] [Abstract][Full Text] [Related]
32. [Biochemical and physiologic principles of tissue-type plasminogen activator].
Lill H
Z Gesamte Inn Med; 1987 Sep; 42(17):478-86. PubMed ID: 3120429
[TBL] [Abstract][Full Text] [Related]
33. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
Sabovic M; Lijnen HR; Keber D; Collen D
Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
[TBL] [Abstract][Full Text] [Related]
34. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion.
Anand S; Kudallur V; Pitman EB; Diamond SL
Ann Biomed Eng; 1997; 25(6):964-74. PubMed ID: 9395042
[TBL] [Abstract][Full Text] [Related]
36. [A method for determining plasmin by the rate of fibrin gel lysis].
Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF
Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408
[TBL] [Abstract][Full Text] [Related]
37. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
38. VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.
Ratel D; Mihoubi S; Beaulieu E; Durocher Y; Rivard GE; Gingras D; Béliveau R
Thromb Res; 2007; 121(2):203-12. PubMed ID: 17512973
[TBL] [Abstract][Full Text] [Related]
39. Fibrin-specific thrombolytic agents.
Collen D
Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
[TBL] [Abstract][Full Text] [Related]
40. Stretching single fibrin fibers hampers their lysis.
Li W; Lucioni T; Li R; Bonin K; Cho SS; Guthold M
Acta Biomater; 2017 Sep; 60():264-274. PubMed ID: 28754649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
